Biosynex SA (EPA:ALBIO)
France
· Delayed Price · Currency is EUR 0.800
+0.016 (2.04%)
Apr 29, 2026, 11:12 AM CET
Biosynex Revenue
Biosynex had revenue of 50.53M EUR in the half year ending June 30, 2025, with 18.46% growth. This brings the company's revenue in the last twelve months to 97.95M, down -5.87% year-over-year. In the year 2024, Biosynex had annual revenue of 101.17M with 8.81% growth.
Revenue (ttm)
97.95M
Revenue Growth
-5.87%
P/S Ratio
0.15
Revenue / Employee
215.76K
Employees
454
Market Cap
14.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 101.17M | 8.19M | 8.81% |
| Dec 31, 2023 | 92.98M | -103.61M | -52.70% |
| Dec 31, 2022 | 196.59M | -185.95M | -48.61% |
| Dec 31, 2021 | 382.53M | 228.64M | 148.57% |
| Dec 31, 2020 | 153.90M | 118.72M | 337.54% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mauna Kea Technologies | 8.91M |
| Ikonisys | 1.47M |
| Novacyt | 22.69M |
| SpineGuard | 3.76M |
| Bluelinea Société Anonyme | 11.68M |
| Theraclion | 2.32M |
| Implanet | 12.47M |
| Diagnostic Medical Systems | 49.47M |